Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Brendon J Coventry, Dominique Baume & Carrie Lilly. (2015) Long-term survival in advanced melanoma patients using repeated therapies: successive immunomodulation improving the odds?. Cancer Management and Research 7, pages 93-103.
Read now
Read now
Michelle D Hackshaw, Arun Krishna & David J Mauro. (2012) Retrospective US database analysis of drug utilization patterns, health care resource use, and costs associated with adjuvant interferon alfa-2b therapy for treatment of malignant melanoma following surgery. ClinicoEconomics and Outcomes Research 4, pages 169-176.
Read now
Read now
Mohammad K Khan, Niloufer Khan, Alex Almasan & Roger Macklis. (2011) Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents. OncoTargets and Therapy 4, pages 137-148.
Read now
Read now
Pamela N Munster & Adil I Daud. (2011) Preclinical and clinical activity of the topoisomerase I inhibitor, karenitecin, in melanoma. Expert Opinion on Investigational Drugs 20:11, pages 1565-1574.
Read now
Read now